Kyverna Therapeutics (KYTX) Earnings Date & Reports
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KYTX is expected to report earnings to rise 63.64% to -108 cents per share on August 18
Q2'26
Est.
$-1.08
Q1'26
Beat
by $0.38
Q4'25
Beat
by $0.21
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.05
The last earnings report on May 12 showed earnings per share of -66 cents, beating the estimate of -103 cents. With 98.49K shares outstanding, the current market capitalization sits at 504.90M.